Memoriu cercetare


Domnului Traian Basescu, Presedinte al Romaniei,
Domnului Prim-Ministru al Romaniei,

Ingrijorati, cercetatorii de origine romana din diaspora doresc sa va semnaleze ca reducerea drastica a finantarii cercetarii romanesti inseamna distrugerea acestei activitati in Romania, tocmai in momentul in care devenea tot mai vizibila pe plan international. Dezvoltarea cercetarii din ultima perioada este rezultatul firesc al unor eforturi comune: ale guvernantilor pentru finantarea cercetarii si ale cercetatorilor pentru judicioasa utilizare a fondurilor castigate prin competitii de proiecte.

Reducerea efortului de finantare vine si in contradictie cu intentia declarata a politicii romanesti de a atrage repatrierea personalitatilor afirmate in afara tarii in domeniul cercetarii stiintifice.

In concordanta cu Petitia initiata de Asociatia Ad Astra (asociatia comunitatii stiintifice romanesti), petitie semnata de aproape 4000 de persoane, in special cercetatori din Romania si strainatate, inaintam aceast memoriu complementar, focalizat pe bugetul activitatii de cercetare.

Solicitam urmatoarele:

  • alocarea pentru cercetare, de la bugetul de stat, a unui procent care sa faca posibila atingerea tintei de 1% din PIB, pana in 2011 sau 2012, conform politicii guvernamentale;
  • finantarea integrala a proiectelor aflate deja in derulare, chiar si in situatia in care obiectivul anterior nu poate fi atins;
  • continuarea finantarii granturilor pentru incurajarea reintoarcerii cercetatorilor romani din strainatate, cu un buget egal sau mai mare decat cel din 2008 si 2009;

    Toate aceste obiective sunt esentiale pentru revenirea specialistilor romani in tara.

    Avantajele repatrierii acestor specialisti ar fi:

    1.crearea unui personal format cu expertiza competitiva la nivel international;

    2. sporirea capacitatii de atragere de fonduri europene destinate cercetarii;

    3. crearea de nuclee pentru transfer de “know-how” la nivel stiintific si tehnologic;

    4. adancirea conexiunilor dintre cercetarea romaneasca si cercetarea din centrele internationale din care cei repatriati provin;

    5. echilibrarea balantei intre exportul si importul de inteligenta romaneasca, in conditiile actualei libertati de miscare a fortei de munca si a celei de a cincea libertati, libertatea cunoasterii;

    6. cresterea in continuare a vizibilitatii stiintei romanesti;

    7. stimularea cresterii economice prin dezvoltarea activitatii de cercetare din sectorul privat (biotehnologic, farmaceutic, medical).

    Reducerea fondurilor pentru cercetare aduce un mare prejudiciu atat cercetarii, cat si societatii romanesti in ansamblu, care are de castigat prin repatrierea oamenilor de valoare afirmati peste hotare.

    Cercetatorii repatriati au deja foarte mult de suferit din cauza reducerii bugetului pentru cercetare, iar daca bugetul final nu va include fondurile necesare unei activitati de cercetare eficiente, o parte dintre ei vor fi nevoiti sa revina in strainatate pentru a-si continua activitatea de stiintifica si a-si mentine standardele la care au ajuns cu eforturi. Aceasta dezamagire va fi resimtita nu doar de specialisti, ci de intreaga diaspora romana, care-si va pierde increderea in capacitatea statului roman de a-si mentine promisiunile.

    Cu ingrijorare si interes pentru binele societatii romanesti,

    Carol Davila Alumni (CDA)

    Harvard Romanian Association (HRA)

    Romanian Student Association at MIT (RSA-MIT)

    1.Octavian Bucur, MD, Postdoctoral Research Fellow, BIDMC & Harvard Medical School, Boston, USA (CDA & HRA)

    2.Rares Pamfil, Harvard University, Boston, USA (HRA)

    3.Victor Velculescu, PhD, Professor, John Hopkins University, Baltimore, USA (Director of Cancer Genetics, Ludwig Center at Johns Hopkins, Co-Director of Cancer Biology, Johns Hopkins Kimmel Cancer Center)

    4.Emanuel Stoica, Massachusetts Institute of Techology (MIT), Boston,USA

    5.Dan Iancu, MIT, Boston, USA (BS: Yale University; MS: Harvard University)

    6.Simona Nedelcu, MIT, Boston, USA (BS: Caltech 2007)

    7.Elisa A. Liehn, MD, PhD, Universitats Klinikum Aachen, Germany

    8.Mircea Leabu, PhD, Head of Cell Biology Laboratory, "Victor Babes" National Institute of Pathology, Bucharest, Romania.

    Pentru a fi adaugat(a) la lista semnatarilor, trimiteti un email la octavian.bucur (at) gmail.com, mentionand si ocupatia dvs. curenta

    Organizatii semnatare:

  • AD ASTRA (proiect online pentru comunitatea stiintifica romaneasca)

  • STANFORD Romanian Student Association (Stanford RSA), Stanford University, USA

  • Association of Romanians at CALTECH (California Institute of Technology; ARCA) USA

  • BOSTON Romanian Biomedical Research Club (BRBRC), USA

    Semnatari

    (Doctorat = PhD; Master = MSc; Facultate=BS; Facultatea de Medicina = MD)

    9.Alexandru Almasan, PhD, Full Professor, Lerner Research Institute, Cleveland Clinic; Head of Radiobiology Program, at Cleveland Clinic & Co-leadear of the Cell Death Regulation Program in Case Comprehensive Cancer Center, Cleveland, OH, USA (Postdoc: Salk Institute for Biological Studies; PhD: University of South Carolina).

    10.Mircea Ivan, MD, PhD, Assistant Professor of Medicine, Indiana University School of Medicine (MD: Universitatea de Medicina si Farmacie „Carol Davila”, Bucuresti; PhD: Cardiff University, UK)

    11.Lucian Moldovan, PhD, Postdoctoral Research Fellow, Dept. of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston USA (BS: Facultatea de Biologie, Universitatea din Bucuresti 2001; PhD: Max Planck Institute of Biochemistry, Munich, Germany 2006)

    12.Claudia Nicolae, PhD, Postdoctoral Research Fellow, Dept. Developmental Biology, Harvard School of Dental Medicine, Boston USA (BS: Facultatea de Biologie, Universitatea din Bucuresti 2001; PhD: Max Planck Institute of Biochemistry, Munich, Germany 2007)

    13.Ovidiu Sirbu, PhD, Postdoctoral Research Fellow, Institute for Biochemistry for Biochemistry and Molecular Biology, Universitat Ulm, Germany

    14.Sergiu P. Pasca, M.D, Postdoctoral Research Fellow, Department of Neurobiology, Stanford University School of Medicine, CA, USA (MD: Facultatea de Medicina, Universitatea de Medicina si Farmacie "Iuliu Hatieganu", Cluj-Napoca in 2007)

    15.Florin Albeanu, PhD, Cold Spring Harbor Laboratory Fellow, CSHL, USA (BS: MIT 2001, PhD: Harvard 2008)

    16.Nicolae Done, Harvard College 2009, Biochemical Sciences

    17.Dan Duda, MD PhD, Assistant Professor at MGH, Harvard Medical School, Boston, MA, USA (MD: Univ. Gr T Popa din Iasi in 1993)

    18.Nicanor I. Moldovan, Ph.D, Assistant Professor in Departments of Internal Medicine/Cardiology and Ophthalmology and Biomedical Engineering, Davis Heart and Lung Research Institute (BS: Facultatea de Fizica Bucuresti in 1981 (Biofizica); PhD: Institutul de Biologie si Patologie Celulara "N. Simionescu" (Universitatea Bucuresti) in 1995)

    19.Adrian Salic, Ph.D., Assistant Porfessor, Department of Cell Biology, Harvard University, Boston, Massachusetts (PhD: Harvard University)

    20.Luminita Pojoga, Instructor of Medicine/Associate Physiologist, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA (BS: Universitatea Bucuresti (Facultatea de Fizica); MSc: Universite Claude Bernard Lyon I; PhD: Clemson University)

    21.Mihai Ionac, MD PhD, Profesor, UMF “Victor Babes”, Timisoara (MD: UMF Iuliu Hatieganu in 1990; PhD: Univ Friedrich Alexander, Erlangen Nurnberg

    22.Mihai Podgoreanu, MD, Assistant Professor of Anesthesiology, Duke University School of Medicine, USA (MD: UMF “Carol Davila” din Bucuresti in 1993; Rezidentiat: Yale University in 2000; Fellowships: Duke University in Cardiothoracic Anesthesia, Critical Care si Molecular Genetics in 2003)

    23.Octavian Voiculescu, Research Fellow, University College London, Cell & Developmental Biology, Gower Street, London WC1E 6BT, U.K. (BS: Universitatea Bucuresti, Facultatea de Chimie (Biochimie) / Uni. Claude Bernard - Lyon I (France); MS: U. Pierre & Marie Curie - Paris VI (France); PhD: Ecole Normale Superieure, Paris)

    24.Razvan Florian, Centrul pentru Cercetari Cognitive si Neuronale (Coneural), Cluj-Napoca, Romania (BS: Universitatea Paris Sud – Orsay)

    25.Akos Z SZABO, MD, Postdoctoral Fellow, Institute for Regeneration Medicine, University of California San Francisco, CA, USA (MD: Facultatea de Medicina a Universitatii de Medicina si Farmacie Iuliu Hatieganu din Cluj Napoca 2007)

    26.George Calin, MD, PhD, Associate Professor, University of Texas, M.D. Anderson Cancer Center, Experimental Therapeutics Department. (MD & PhD: Universitatea de Medicina, UMF „Carol Davila” Bucuresti)

    27.Ovidiu Andronesi, MD, PhD, Postdoctoral Researc Fellow in Neuroimagistica medicala, Dept of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA (BS: Facultatea de Fizica, Universitatea din Bucuresti; MD: UMF „Carol Davila” Bucuresti; PhD: Biofizica, Max Planck Institute for Biophysical Chemistry)

    28.Laura Burga, PhD, Postdoctoral Research Fellow, Beth Israel Deacones Medical Center, Harvard Medical School, Boston, USA (BS: Facultatea de Biologie, Universitatea Ovidius, Constanta 1998; Postdoc: Faculty of Pharmacy, Philipps University, Marburg, Germany 2005)

    29.Cristian Boboila, PhD candidate – Immunology Program, Harvard University (BS: Yale University )

    30.Daniel Nedelcu, PhD candidate, Harvard University (BS: chimie & biologie, Massachusetts Institute of Technology (MIT) 2006)

    31.Cezar Petriuc, PhD candidate, Stanford University, USA; President of Stanford Romanian Student Association (BS: Stanford University 2002; MS: Stanford University 2003)

    32.Sabina Alistar, PhD candidate, Stanford University, USA (BS: Stanford University; MS: Stanford University 2005)

    33.Florea Lupu, PhD, Principal Investigator and Associate Member, Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation; Associate Professor, Oklahoma University Health Sciences Center, USA (BS: Facultatea de Biologie, Universitatea Babes-Bolyai din Cluj-Napoca; PhD: Institutul de Biologie si Patologie Celulara din Bucuresti)

    34.Ioana Aanei, class of 2011, BS in Chemistry, California Institute of Technology, CA, USA

    35.Ana Balibanu, 2011, BS in Mathematics, California Institute of Technology, California Institute of Technology, CA, USA

    36.Alexandra Velian, 2009, BS in Chemistry, California Institute of Technology, CA, USA

    37.Alexandra Musat, 2012, BS in Mathematics, California Institute of Technology, CA, USA

    38.Dan Betea, 2012, PhD in Mathematics, California Institute of Technology, CA, USA

    39.Mihai Florin, 2012, PhD in Computer Science, California Institute of Technology, CA, USA

    40.Sebastian Zavoian, MD, Postdoctoral Research Fellow, University of Virginia, Neurosurgery Department (MD: UMF Carol Davila, Bucuresti, 2004)

    41.Stefan Spulber, MD, PhD, Postdoctoral Research Fellow, Karolinska Institute, Dept. of Neuroscience, Stockholm, Sweden (MD: Universitatea de Medicina si Farmacie „Carol Davila”, Bucuresti; PhD: Karolinska Institutet, Sweden)

    42.Alina Codita, MD, PhD student, Karolinska Institute, Stockholm, Sweden (MD: Universitatea de Medicina si Farmacie „Carol Davila”, Bucuresti)

    43.Michael Mihai Dediu, Sr. International Management & Research Consultant at Derc, Inc. (PhD: Matematica, Universitatea din Bucuresti)

    44.Zorina Galis, Ph.D., Professor, Department of Surgery, Indiana University School of Medicine (MSc: Biofizica, Universitatea Bucuresti; PhD: Patologie, McGill School of Medicine, Montreal, Canada; Post-doctorat: Medicina Vasculara, Harvard Medical School, Boston, USA).

    45.Daniela Matei, MD, Associate Professor, Department of Medicine, Hematology-Oncology, Co-Leader Experimental Therapeutics Program, Indiana University Bren and Melvin Simon Cancer Center, Indianapolis, IN, USA (MD: UMF Carol Davila, Bucuresti)